Renovis specializes in building cohesive relationships with medical professionals and civic organizations to improve coordinated care and address the clinical ...
Renovis, Inc. was a biopharmaceutical company developing drugs to treat neurological diseases and disorders. Renovis, Inc. was acquired by Evotec AG in 2008 ...
Renovis Hip Product Group Renovis Knee Product Group Renovis Spine Product Group Renovis Trauma Product Group Renovis biologics Product Group. Technology ...
Same-Day Diagnostic and Lab procedures with same day results through our Enhanced Care Management Services. Renovis provides for the assessment, identification ...
"The acquisition enhances Evotec's emerging clinical story. Our three clinical candidates are now backed by a strong late stage preclinical pipeline focusing on ...
Jan 16, 2019 · The assets will be transferred into a new California-based company wholly owned by Kyocera International, Inc., to be named Kyocera Medical ...
Renovis, founded in 2001, was a biopharmaceutical company seeking to improve the lives of patients suffering from neurological disease with novel drugs…
Renovis Announces the Departure of Chief Medical Officer. Randall W. Moreadith, M.D., Ph.D. — Company Also Reports Option Grants Under NASDAQ Rule 4350 —.
Renovis Surgical Technologies develops, manufactures, and sells orthopedic medical implants to surgeons and hospitals.
Operator of a biopharmaceutical company developing drugs to treat neurological diseases and disorders. The company used molecular biology, medicinal chemistry, ...